On Friday, RAPT Therapeutics Inc (NASDAQ: RAPT) opened lower -13.78% from the last session, before settling in for the closing price of $1.41. Price fluctuations for RAPT have ranged from $0.79 to $9.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -36.87%. Company’s average yearly earnings per share was noted 81.30% at the time writing. With a float of $68.90 million, this company’s outstanding shares have now reached $132.01 million.
Let’s determine the extent of company efficiency that accounts for 68 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
RAPT Therapeutics Inc (RAPT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of RAPT Therapeutics Inc is 47.81%, while institutional ownership is 45.20%.
RAPT Therapeutics Inc (RAPT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 42.80% during the next five years compared to -10.10% drop over the previous five years of trading.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
Check out the current performance indicators for RAPT Therapeutics Inc (RAPT). In the past quarter, the stock posted a quick ratio of 4.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.12, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
Looking closely at RAPT Therapeutics Inc (NASDAQ: RAPT), its last 5-days average volume was 1.04 million, which is a jump from its year-to-date volume of 0.89 million. As of the previous 9 days, the stock’s Stochastic %D was 57.48%. Additionally, its Average True Range was 0.12.
During the past 100 days, RAPT Therapeutics Inc’s (RAPT) raw stochastic average was set at 17.02%, which indicates a significant decrease from 33.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 121.46% in the past 14 days, which was lower than the 172.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1925, while its 200-day Moving Average is $1.8900. However, in the short run, RAPT Therapeutics Inc’s stock first resistance to watch stands at $1.3550. Second resistance stands at $1.4900. The third major resistance level sits at $1.5750. If the price goes on to break the first support level at $1.1350, it is likely to go to the next support level at $1.0500. Should the price break the second support level, the third support level stands at $0.9150.
RAPT Therapeutics Inc (NASDAQ: RAPT) Key Stats
There are currently 132,007K shares outstanding in the company with a market cap of 161.05 million. Presently, the company’s annual sales total 0 K according to its annual income of -129,870 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -53,250 K.
